|
|
Guillermo Torres, & Debora Gil. (2020). A multi-shape loss function with adaptive class balancing for the segmentation of lung structures. IJCAR - International Journal of Computer Assisted Radiology and Surgery, 15(1), S154–55.
|
|
|
|
Guillermo Torres, Debora Gil, Antoni Rosell, S. Mena, & Carles Sanchez. (2023). Virtual Radiomics Biopsy for the Histological Diagnosis of Pulmonary Nodules – Intermediate Results of the RadioLung Project. IJCARS - International Journal of Computer Assisted Radiology and Surgery, .
|
|
|
|
Juan Borrego-Carazo, Carles Sanchez, David Castells, Jordi Carrabina, & Debora Gil. (2022). A benchmark for the evaluation of computational methods for bronchoscopic navigation. IJCARS - International Journal of Computer Assisted Radiology and Surgery, 17(1).
|
|
|
|
Antoni Rosell, Sonia Baeza, S. Garcia-Reina, JL. Mate, Ignasi Guasch, I. Nogueira, et al. (2022). Radiomics to increase the effectiveness of lung cancer screening programs. Radiolung preliminary results. ERJ - European Respiratory Journal, 60(66).
|
|
|
|
David Roche, Debora Gil, & Jesus Giraldo. (2013). Multiple active receptor conformation, agonist efficacy and maximum effect of the system: the conformation-based operational model of agonism,. DDT - Drug Discovery Today, 18(7-8), 365–371.
Abstract: The operational model of agonism assumes that the maximum effect a particular receptor system can achieve (the Em parameter) is fixed. Em estimates are above but close to the asymptotic maximum effects of endogenous agonists. The concept of Em is contradicted by superagonists and those positive allosteric modulators that significantly increase the maximum effect of endogenous agonists. An extension of the operational model is proposed that assumes that the Em parameter does not necessarily have a single value for a receptor system but has multiple values associated to multiple active receptor conformations. The model provides a mechanistic link between active receptor conformation and agonist efficacy, which can be useful for the analysis of agonist response under different receptor scenarios.
|
|
